Sophie R Cohen
Affiliations: | Drexel University College of Medicine, Philadelphia, PA, United States |
Area:
Dopamine, DAT, Dopamine Receptors, Motivation, Sleep, PDGoogle:
"Sophie Cohen"Mean distance: (not calculated yet)
Parents
Sign in to add mentorChristopher R. Bishop | research assistant | 2019-2022 | Binghamton University (SUNY) | |
(Undergraduate Honors Research) | ||||
Rodrigo Espana | grad student | 2021- | Drexel | |
(Graduate Training) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Centner A, Del Priore I, Chambers N, et al. (2024) Deficits in basal and evoked striatal dopamine release following alpha-synuclein preformed fibril injection: An in vivo microdialysis study. The European Journal of Neuroscience |
Budrow C, Elder K, Coyle M, et al. (2023) Broad Serotonergic Actions of Vortioxetine as a Promising Avenue for the Treatment of L-DOPA-Induced Dyskinesia. Cells. 12 |
Lipari N, Centner A, Glinski J, et al. (2022) Characterizing the relationship between L-DOPA-induced-dyskinesia and psychosis-like behaviors in a bilateral rat model of Parkinson's disease. Neurobiology of Disease. 105965 |
Cohen SR, Terry ML, Coyle M, et al. (2022) The multimodal serotonin compound Vilazodone alone, but not combined with the glutamate antagonist Amantadine, reduces l-DOPA-induced dyskinesia in hemiparkinsonian rats. Pharmacology, Biochemistry, and Behavior. 217: 173393 |
Cohen SR, Terry ML, Coyle, et al. (2022) The multimodal serotonin compound Vilazodone alone, but not combined with the glutamate antagonist Amantadine, reduces l-DOPA-induced dyskinesia in hemiparkinsonian rats Pharmacology, Biochemistry & Behavior. 217: 173393 |
Smith S, Sergio J, Coyle M, et al. (2022) The effects of Vilazodone, YL-0919 and Vortioxetine in hemiparkinsonian rats. Psychopharmacology |